Skip to main content
Top
Published in: Breast Cancer Research 2/2005

01-06-2005 | Poster Presentation

BRCA1 directly modulates gene expression required for estrogen biosynthesis: a possible mechanism of tissue-specific tumor suppression

Authors: Y Hu, S Aiyar, W Yue, S Ghosh, Y Lu, R Li

Published in: Breast Cancer Research | Special Issue 2/2005

Login to get access

Excerpt

Mutations in the tumor suppressor gene BRCA1 are associated with an elevated risk of breast and ovarian cancer. The tissue-specific nature of BRCA1 mutation-associated tumors stands in stark contrast to the diverse array of nuclear functions mediated by the wild-type BRCA1. These functions include regulation of transcription and the DNA damage response. While the DNA repair function of BRCA1 clearly contributes to overall genetic stability, loss of BRCA1 function in DNA repair, a process that is universally important to all cell types in both genders, cannot easily explain why BRCA1 mutations predominantly affect breast and ovary, two major estrogen-responsive tissues in women. We hypothesize that BRCA1 confers tissue-specific tumor suppression by directly modulating expression of a set of breast-cancer-related genes. …
Metadata
Title
BRCA1 directly modulates gene expression required for estrogen biosynthesis: a possible mechanism of tissue-specific tumor suppression
Authors
Y Hu
S Aiyar
W Yue
S Ghosh
Y Lu
R Li
Publication date
01-06-2005
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue Special Issue 2/2005
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr1115

Other articles of this Special Issue 2/2005

Breast Cancer Research 2/2005 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine